SCHEDULE 13D/A
SCHEDULE 13D/ASchedule 13D ownership disclosure
Organogenesis Holdings Inc
Class A Common Stock, par value $0.0001 per share · CUSIP: 68621F102
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Alan A. AdesReported CIK 0001757286
Shares: 22,319,837 · Class: 17.8%
- Albert Erani
Shares: 17,920,498 · Class: 14.3%
- Glenn H. Nussdorf
Shares: 11,912,841 · Class: 9.5%
- Dennis Erani
Shares: 10,043,701 · Class: 8%
- Starr Wisdom
Shares: 20,000 · Class: 0%
- Organo PFG LLC
Shares: 8,279,490 · Class: 6.6%
- Organo Investors LLC
Shares: 2,851,984 · Class: 2.3%
- Alan Ades 2014 GRAT
Shares: 3,075,865 · Class: 2.4%
- Albert Erani Family Trust dated 12/29/2012
Shares: 0 · Class: 0%
- Dennis Erani 2012 Issue Trust dated 12/20/12
Shares: 8,382,031 · Class: 6.7%
- GN 2016 Family Trust u/a/d August 12, 2016
Shares: 918,680 · Class: 0.7%
- GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016
Shares: 8,871,320 · Class: 7.1%
- RED Holdings, LLC
Shares: 6,784,024 · Class: 5.4%
- Josette Ades
Shares: 1,710,552 · Class: 1.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-001352
- Form type
- SCHEDULE 13D/A
- Filer
- Ades Alan A.
- CIK
- CIK 1757286
- Filed
- Jan 03, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13D beneficial ownership